VG Life Sciences, Inc.(Other OTC/NBB : VRAL)
VRAL PreMarket: $ () as of AM
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Consumer Services » Other Consumer Services
VG Life Sciences, Inc. operates as a development stage biotechnology company, which engages on discovering and developing drug therapies for cancer, infectious disease, and inflammatory autoimmune disorders. The company is currently focused on researching two technologies namely Targeted Peptide Technology which targets the body's immune cells and seems to explain the mechanism behind some autoimmune diseases while presenting a possible solution and Metabolic Disruption Technology which can be used in combination with a variety of existing drugs and compounds to treat drug resistant cancers. The company was founded by Haig Keledjian in 1994 and is headquartered in San Marino, CA.